ICARES Medicus, Inc. (TPEX:6612)
58.80
+1.20 (2.08%)
Nov 20, 2026, 1:30 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 361.96M TWD in the quarter ending September 30, 2026, with 37.32% growth. This brings the company's total for the last twelve months to 1.31B, up 20.37% year-over-year. In the year 2025, ICARES Medicus had annual revenue of 1.13B with 31.54% growth. That makes ICARES Medicus the 29,649th largest company in the world by revenue and 1,439th in Taiwan.
Revenue (ttm)
1.31B
Revenue Growth
+20.37%
P/S Ratio
2.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.05B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full ICARES Medicus breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | 271.19M | 31.54% |
| Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
| Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
| Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
| Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| Formosa Optical Technology | 4.46B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Nang Kuang Pharmaceutical | 2.09B |
| Bionime | 1.73B |
| Chi Sheng Pharma & Biotech | 1.43B |
| Crystalvue Medical | 894.60M |